Crinetics Pharmaceuticals, Inc.
CRNXNASDAQ
Healthcare
Biotechnology
$37.10
+0.54(1.5%)
52W $25.56 – $56.43
Quick:
8-K
Mar 23, 2026 (2 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 3, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 26, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Feb 26, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 5, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 26, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 13, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 7, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 5, 2026 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 17, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 12, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 6, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Sep 26, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Sep 8, 2025 (7 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Aug 12, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Aug 7, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 7, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 30, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 26, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction